NEW YORK (Reuters Health) – Appropriate use of intravenous narcotics is safe and perhaps even beneficial in patients with acute coronary syndromes, according to Israeli researchers. In general,…
NEW YORK (Reuters Health) – A new practice parameter from the American Academy of Neurology calls for doctors to identify and treat nonmotor symptoms in patients with Parkinson’s…
NEW YORK (Reuters Health) – Drug-eluting stents in saphenous vein grafts have a lower risk of revascularization than bare-metal stents, according to a meta-analysis of data on nearly…
NEW YORK (Reuters Health) – As first-line treatment for progressive chronic lymphocytic leukemia (CLL), cladribine and fludarabine are equally effective and safe in combination with cyclophosphamide, according to…
NEW YORK (Reuters Health) – Use of insulin glargine or detemir rather than NPH insulin does not reduce the risk of ketoacidosis in children and adolescents with type…
NEW YORK (Reuters Health) – There’s no good evidence that maintenance therapy improves the outcome of small-cell lung cancer (SCLC), according to a meta-analysis published February 25th in…
NEW YORK (Reuters Health) – Some patients with ocular hypertension are at low risk of progressing to open-angle glaucoma and don’t need treatment, research shows. But for patients…
NEW YORK (Reuters Health) – When statins alone can’t reverse dyslipidemia, the thyroid hormone analogue eprotirome may be helpful, new research suggests. In a 12-week study of 189…
NEW YORK (Reuters Health) – Four out of five children with juvenile idiopathic arthritis had a good clinical response to abatacept during a long-term open-label extension trial. The…
NEW YORK (Reuters Health) – Statin use by women cuts their risk of primary cardiovascular disease (CVD) events by roughly a third, which is similar to the risk…